Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...
Immunocompromised people and those who are over 65 years of age or older should get a second dose of this year’s COVID-19 ...
GlobalData on MSN2d
Moderna’s norovirus vaccine enters Phase III trials in the UKThere are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.
Many people don’t know they’re eligible. | Moderna has identified a fundamental barrier to vaccination: many people don’t ...
Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...
Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...
Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle ...
The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...
The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback